Reed, Shelby D.; Radeva, Jasmina I.; Daniel, Davey B.; … - In: PharmacoEconomics 24 (2006) 5, pp. 479-494
Introduction: A 16-week, open-label, multicentre, randomised trial of weekly epoetin alfa 40_000 units versus biweekly darbepoetin alfa 200mug among 358 patients with solid-tumour cancers and chemotherapy-induced anaemia demonstrated superior haematological outcomes with epoetin alfa. We sought...